The pathophysiology of HOX genes and their role in cancer

Journal of Pathology

Volumn 205, Issue 2, 2005, Pages 154-171

  Grier, D G ^a   Thompson, A ^a   Kwasniewska, A ^a   McGonigle, G J ^a   Halliday, H L ^a,b   Lappin, T R ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL MATERNITY HOSPITAL   (United Kingdom)

Author keywords

Cancer; Embryogenesis; Haematopoiesis; Homeobox; HOX; Leukaemia

Indexed keywords

HOMEODOMAIN PROTEIN; HOX PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEOPORIN 98;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; APOPTOSIS; BRACHYDACTYLY; BREAST CANCER; CANCER CLASSIFICATION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; COLORECTAL CANCER; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; DROSOPHILA; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE FUSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC CONSERVATION; GROWTH REGULATION; HAND FOOT SYNDROME; HEMATOPOIETIC STEM CELL; HUMAN; KIDNEY CANCER; LEUKEMIA; LIMB MALFORMATION; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MELANOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; POLYDACTYLY; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; THYROID CANCER; UTERINE CERVIX CANCER;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, HOMEOBOX; HEMATOPOIESIS; HUMANS; LEUKEMIA; NEOPLASMS;

EID: 13644265950     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1710     Document Type: Review

References (151)

1. Garcia-Bellido A. Homeotic and atavic mutations in insects. Am Zool 1977; 17: 613-629.
2. Bridges CB, Morgan TH. The third-chromosome group of mutant characters of Drosophila melanogaster. Publ Carnegie Inst 1923; 327: 1-251.
3. Duboule D. The vertebrate limb: a model system to study the Hox/HOM gene network during development and evolution. Bioessays 1992; 14: 375-384.
4. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 1978; 276: 565-570.
5. Gehring WJ, Affolter M, Burglin T. Homeodomain proteins. Annu Rev Biochem 1994; 63: 487-526.
6. Tupler R, Perini G, Green MR. Expressing the human genome. Nature 2001; 409: 832-833.
7. Krumlauf R. Hox genes in vertebrate development. Cell 1994; 78: 191-201.
8. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059-1064.
9. Buske C, Humphries RK. Homeobox genes in leukemogenesis. Int J Hematol 2000; 71: 301-308.
10. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nature Rev Cancer 2002; 2: 777-785.
11. Kmita M, Duboule D. Organizing axes in time and space; 25 years of colinear tinkering. Science 2003; 301: 331-333.
12. St Johnston D, Nusslein-Volhard C. The origin of pattern and polarity in the Drosophila embryo. Cell 1992; 68: 201-219.
13. Driever W, Nusslein-Volhard C. A gradient of bicoid protein in Drosophila embryos. Cell 1988; 54: 83-93.
14. Hulskamp M, Tautz D. Gap genes and gradients - the logic behind the gaps. Bioessays 1991; 13: 261-268.
15. Small S, Levine M. The initiation of pair-rule stripes in the Drosophila blastoderm. Curr Opin Genet Dev 1991; 1: 255-260.
16. Hanson RD, Hess JL, Yu BD, et al. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc Natl Acad Sci U S A 1999; 96: 14 372-14 377.
17. Casares F, Mann RS. Control of antennal versus leg development in Drosophila. Nature 1998; 392: 723-726.
18. Postlethwait JH, Schneiderman HA. A clonal analysis of determination in Antennapedia, a homoeotic mutant of Drosophila melanogaster. Proc Natl Acad Sci U S A 1969; 64: 176-183.
19. Suemori H, Noguchi S. Hox C cluster genes are dispensable for overall body plan of mouse embryonic development. Dev Biol 2000; 220: 333-342.
20. Wellik DM, Capecchi MR. Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton. Science 2003; 301: 363-367.
21. Duboule D. Temporal colinearity and the phylotypic progression: a basis for the stability of a vertebrate Bauplan and the evolution of morphologies through heterochrony. Dev Suppl 1994; 135-142.
22. Nelson CE, Morgan BA, Burke AC, et al. Analysis of Hox gene expression in the chick limb bud. Development 1996; 122: 1449-1466.
23. Mollard R, Dziadek M. Homeobox genes from clusters A and B demonstrate characteristics of temporal colinearity and differential restrictions in spatial expression domains in the branching mouse lung. Int J Dev Biol 1997; 41: 655-666.
24. Golpon HA, Geraci MW, Moore MD, et al. HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol 2001; 158: 955-966.
25. Sakiyama J, Yokouchi Y, Kuroiwa A. Coordinated expression of Hoxb genes and signaling molecules during development of the chick respiratory tract. Dev Biol 2000; 227: 12-27.
26. Bogue CW, Gross I, Vasavada H, Dynia DW, Wilson CM, Jacobs HC. Identification of Hox genes in newborn lung and effects of gestational age and retinoic acid on their expression. Am J Physiol 1994; 266: L448-L454.
27. Volpe MV, Pham L, Lessin M, et al. Expression of Hoxb-5 during human lung development and in congenital lung malformations. Birth Defects Res Part A Clin Mol Teratol 2003; 67: 550-556.
28. Aubin J, Lemieux M, Tremblay M, Berard J, Jeannotte L. Early postnatal lethality in Hoxa-5 mutant mice is attributable to respiratory tract defects. Dev Biol 1997; 192: 432-445.
29. Sayli BS, Akarsu AN, Sayli U, Akhan O, Ceylaner S, Sarfarazi M. A large Turkish kindred with syndactyly type II (synpolydactyly). 1. Field investigation, clinical and pedigree data. J Med Genet 1995; 32: 421-434.
30. Sarfarazi M, Akarsu AN, Sayli BS. Localization of the syndactyly type II (synpolydactyly) locus to 2q31 region and identification of tight linkage to HOXD8 intragenic marker. Hum Mol Genet 1995; 4: 1453-1458.
31. Goodman FR, Mundlos S, Muragaki Y, et al. Synpolydactyly phenotypes correlate with size of expansions in HOXD13 polyalanine tract. Proc Natl Acad Sci U S A 1997; 94: 7458-7463.
32. Goodman F, Giovannucci-Uzielli ML, Hall C, Reardon W, Winter R, Scambler P. Deletions in HOXD13 segregate with an identical, novel foot malformation in two unrelated families. Am J Hum Genet 1998; 63: 992-1000.
33. Akarsu AN, Stoilov I, Yilmaz E, Sayli BS, Sarfarazi M. Genomic structure of HOXD13 gene: a nine polyalanine duplication causes synpolydactyly in two unrelated families. Hum Mol Genet 1996; 5 945-952.
34. Muragaki Y, Mundlos S, Upton J, Olsen BR. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 1996; 272: 548-551.
35. Oude Luttikhuis ME, Williams DK, Trembath RC. Isolated autosomal dominant type E brachydactyly: exclusion of linkage to candidate regions 2q37 and 20q13. J Med Genet 1996; 33: 873-876.
36. Johnson D, Kan SH, Oldridge M, et al. Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E. Am J Hum Genet 2003; 72: 984-997.
37. Mortlock DP, Post LC, Innis JW. The molecular basis of hypodactyly (Hd): a deletion in Hoxa 13 leads to arrest of digital arch formation. Nature Genet 1996; 13: 284-289.
38. Mortlock DP, Innis JW. Mutation of HOXA13 in hand-foot-genital syndrome. Nature Genet 1997; 15: 179-180.
39. Goodman FR, Bacchelli C, Brady AF, et al. Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 2000; 67: 197-202.
40. Utsch B, Becker K, Brock D, Lentze MJ, Bidlingmaier F, Ludwig M. A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene associated with hand-foot-genital syndrome: proper function of poly(A)-harbouring transcription factors depends on a critical repeat length? Hum Genet 2002; 110: 488-494.
41. Del Campo M, Jones MC, Veraksa AN, et al. Monodactylous limbs and abnormal genitalia are associated with hemizygosity for the human 2q31 region that includes the HOXD cluster. Am J Hum Genet 1999; 65: 104-110.
42. Debeer P, Bacchelli C, Scambler PJ, De Smet L, Fryns JP, Goodman FR. Severe digital abnormalities in a patient heterozygous for both a novel missense mutation in HOXD13 and a polyalanine tract expansion in HOXA13. J Med Genet 2002; 39: 852-856.
43. Shrimpton AE, Levinsohn EM, Yozawitz JM, et al. A HOX gene mutation in a family with isolated congenital vertical talus and Charcot-Marie-tooth disease. Am J Hum Genet 2004; 75: 92-96.
44. Kantaputra PN, Gorlin RJ, Langer LO Jr. Dominant mesomelic dysplasia, ankle, carpal, and tarsal synostosis type: a new autosomal dominant bone disorder. Am J Med Genet 1992; 44: 730-737.
45. Fujimoto M, Kantaputra PN, Ikegawa S, et al. The gene for mesomelic dysplasia Kantaputra type is mapped to chromosome 2q24-q32. J Hum Genet 1998; 43: 32-36.
46. Goodman FR, Majewski F, Collins AL, Scambler PJ. A 117-kb microdeletion removing HOXD9-HOXD13 and EVX2 causes synpolydactyly. Am J Hum Genet 2002; 70: 547-555.
47. Branch S, Francis BM, Brownie CF, Chernoff N. Teratogenic effects of the demethylating agent 5-aza-2′-deoxycytidine in the Swiss Webster mouse. Toxicology 1996; 112: 37-43.
48. Branch S, Henry-Sam G. Altered hox gene expression and cellular pathogenesis of 5-aza-2′-deoxycytidine-induced murine hindlimb dysmorphogenesis. Toxicol Pathol 2001; 29: 501-506.
49. Sauvageau G, Lansdorp PM, Eaves CJ, et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A 1994; 91: 12 223-12 227.
50. Lawrence HJ, Largman C. Homeobox genes in normal hematopoiesis and leukemia. Blood 1992; 80: 2445-2453.
51. Lawrence HJ, Sauvageau G, Ahmadi N, et al. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Exp Hematol 1995; 23: 1160-1166.
52. Pineault N, Helgason CD, Lawrence HJ, Humphries RK. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol 2002; 30 49-57.
53. Giampaolo A, Sterpetti P, Bulgarini D, et al. Key functional role and lineage-specific expression of selected HOXB genes in purified hematopoietic progenitor differentiation. Blood 1994; 84: 3637-3647.
54. Crooks GM, Fuller J, Petersen D, et al. Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood 1999; 94: 519-528.
55. Fuller JF, McAdara J, Yaron Y, Sakaguchi M, Fraser JK, Gasson JC. Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation. Blood 1999; 93: 3391-3400.
56. Izon DJ, Rozenfeld S, Fong ST, Komuves L, Largman C, Lawrence HJ. Loss of function of the homeobox gene Hoxa-9 perturbs early T-cell development and induces apoptosis in primitive thymocytes. Blood 1998; 92: 383-393.
57. Lawrence HJ, Helgason CD, Sauvageau G, et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 1997; 89: 1922-1930.
58. Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 1998; 17: 3714-3725.
59. Kirito K, Fox N, Kaushansky K. Thrombopoietin induces HOXA9 nuclear transport in immature hematopoietic cells: potential mechanism by which the hormone favorably affects hematopoietic stem cells. Mol Cell Biol 2004; 24: 6751-6762.
60. Thorsteinsdottir U, Sauvageau G, Hough MR, et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 1997; 17: 495-505.
61. Bjornsson JM, Larsson N, Brun AC, et al. Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4. Mol Cell Biol 2003; 23: 3872-3883.
62. Sauvageau G, Thorsteinsdottir U, Hough MR, et al. Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 1997; 6 13-22.
63. Sauvageau G, Thorsteinsdottir U, Eaves CJ, et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 1995; 9: 1753-1765.
64. Thorsteinsdottir U, Sauvageau G, Humphries RK. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 1999; 94: 2605-2612.
65. Beslu N, Krosl J, Laurin M, Mayotte N, Humphries RK, Sauvageau G. Molecular interactions involved in HOXB4-induced activation of HSC self-renewal. Blood 2004; 104: 2307-2314.
66. Amsellem S, Pflumio F, Bardinet D, et al. Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nature Med 2003; 9: 1423-1427.
67. Krosl J, Austin P, Beslu N, Kroon E, Humphries RK, Sauvageau G. In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nature Med 2003; 9: 1428-1432.
68. Shen WF, Detmer K, Mathews CH, et al. Modulation of homeobox gene expression alters the phenotype of human hematopoietic cell lines. EMBO J 1992; 11: 983-989.
69. Kappen C. Disruption of the homeobox gene Hoxb-6 in mice results in increased numbers of early erythrocyte progenitors. Am J Hematol 2000; 65: 111-118.
70. Shen W, Chrobak D, Krishnan K, Lawrence HJ, Largman C. HOXB6 protein is bound to CREB-binding protein and represses globin expression in a DNA binding-dependent, PBX interaction-independent process. J Biol Chem 2004; 279: 39 895-39 904.
71. Bijl J, van Oostveen JW, Kreike M, et al. Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue. Blood 1996; 87: 1737-1745.
72. Shimamoto T, Tang Y, Naot Y, et al. Hematopoietic progenitor cell abnormalities in Hoxc-8 null mutant mice. J Exp Zool 1999; 283: 186-193.
73. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
74. Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia 1999; 13: 687-698.
75. Lawrence FU, Rozenfeld S, Cruz C, et al. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 1999; 13: 1993-1999.
76. Dimartino JF, Cleary ML. Mll rearrangements in haematological malignancies: lessons from clinical and biological studies. Br J Haematol 1999; 106: 614-626.
77. So CW, Cleary ML. Dimerization: a versatile switch for oncogenesis. Blood 2004; 104: 919-922.
78. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genet 2002; 30: 41-47.
79. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143.
80. Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 2003; 102: 262-268.
81. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 1995; 378: 505-508.
82. Milne TA, Briggs SD, Brock HW, et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 2002; 10: 1107-1117.
83. Borrow J, Shearman AM, Stanton VP Jr, et al. The t(7;11) (p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nature Genet 1996; 12: 159-167.
84. Nakamura T, Largaespada DA, Lee MP, et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nature Genet 1996; 12: 154-158.
85. Fujino T, Suzuki A, Ito Y, et al. Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15). Blood 2002; 99: 1428-1433.
86. Taketani T, Taki T, Shibuya N, Kikuchi A, Hanada R, Hayashi Y. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13). Cancer Res 2002; 62: 4571-4574.
87. La Starza R, Trubia M, Crescenzi B, et al. Human homeobox gene HOXC13 is the partner of NUP98 in adult acute myeloid leukemia with t(11;12)(p15;q13). Genes Chromosomes Cancer 2003; 36: 420-423.
88. Raza-Egilmez SZ, Jani-Sait SN, Grossi M, Higgins MJ, Shows TB, Aplan PD. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res 1998; 58: 4269-4273.
89. Pineault N, Abramovich C, Ohta H, Humphries RK. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1. Mol Cell Biol 2004; 24: 1907-1917.
90. Drabkin HA, Parsy C, Ferguson K, et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia 2002; 16: 186-195.
91. Thompson A, Quinn MF, Grimwade D, et al. Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Blood 2003; 101: 1558-1565.
92. Debernardi S, Lillington DM, Chaplin T, et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 2003; 37: 149-158.
93. Roche J, Zeng C, Baron A, et al. Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics. Leukemia 2004; 18: 1059-1063.
94. Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 2001; 21: 224-234.
95. Calvo R, West J, Franklin W, et al. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A 2000; 97: 12 776-12 781.
96. Tiberio C, Barba P, Magli MC, et al. HOX gene expression in human small-cell lung cancers xenografted into nude mice. Int J Cancer 1994; 58: 608-615.
97. Lechner JF, Fugaro JM, Wong Y, Pass HI, Harris CC, Belinsky SA. Perspective: cell differentiation theory may advance early detection of and therapy for lung cancer. Radiat Res 2001; 155: 235-238.
98. Lechner JF, Wang Y, Siddiq F, et al. Human lung cancer cells and tissues partially recapitulate the homeobox gene expression profile of embryonic lung. Lung Cancer 2002; 37: 41-47.
99. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 2003; 278: 7580-7590.
100. Ford HL, Kabingu EN, Bump EA, Mutter GL, Pardee AB. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A 1998; 95: 12 608-12 613.
101. de Stanchina E, Gabellini D, Norio P, et al. Selection of homeotic proteins for binding to a human DNA replication origin. J Mol Biol 2000; 299: 667-680.
102. Song K, Wang Y, Sassoon D. Expression of Hox-7.1 in myoblasts inhibits terminal differentiation and induces cell transformation. Nature 1992; 360: 477-481.
103. Woloshin P, Song K, Degnin C, et al. MSX1 inhibits myoD expression in fibroblast × 10T1/2 cell hybrids. Cell 1995; 82 611-620.
104. Dodig M, Tadic T, Kronenberg MS, et al. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev Biol 1999; 209: 298-307.
105. Waltregny D, Alami Y, Clausse N, de Leval J, Castronovo V. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 2002; 50 162-169.
106. Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000; 405: 974-978.
107. Chen H, Chung S, Sukumar S. HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol 2004; 24: 924-935.
108. Cillo C, Cantile M, Mortarini R, Barba P, Parmiani G, Anichini A. Differential patterns of HOX gene expression are associated with specific integrin and ICAM profiles in clonal populations isolated from a single human melanoma metastasis. Int J Cancer 1996; 66 692-697.
109. Gorski DH, Walsh K. The role of homeobox genes in vascular remodeling and angiogenesis. Circ Res 2000; 87: 865-872.
110. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. Induction of the angiogenic phenotype by Hox D3. J Cell Biol 1997; 139: 257-264.
111. Myers C, Charboneau A, Boudreau N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 2000; 148 343-351.
112. Wu Y, Moser M, Bautch VL, Patterson C. HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells. Mol Cell Biol 2003; 23: 5680-5691.
113. Care A, Felicetti F, Meccia E, et al. HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res 2001; 61: 6532-6539.
114. Goodman FR. Limb malformations and the human HOX genes. Am J Med Genet 2002; 112: 256-265.
115. Shim C, Zhang W, Rhee CH, Lee JH. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 1998; 4: 3045-3050.
116. Vider BZ, Zimber A, Hirsch D, et al. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun 1997; 232: 742-748.
117. Miller GJ, Miller HL, van Bokhoven A, et al. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res 2003; 63: 5879-5888.
118. Cillo C, Barba P, Freschi G, Bucciarelli G, Magli MC, Boncinelli E. HOX gene expression in normal and neoplastic human kidney. Int J Cancer 1992; 51: 892-897.
119. Takahashi Y, Hamada J, Murakawa K, et al. Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res 2004; 293: 144-153.
120. Kappen C, Mello MA, Finnell RH, Salbaum JM. Folate modulates Hox gene-controlled skeletal phenotypes. Genesis 2004; 39: 155-166.
121. Luo L, Yang X, Takihara Y, Knoetgen H, Kessel M. The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions. Nature 2004; 427: 749-753.
122. Oh EJ, Park JH, Cho M, Lee WJ, Choi YH, Yoo MA. The caudal-related homeodomain protein CDX1 activates proliferating cell nuclear antigen expression in hepatocellular and colorectal carcinoma cells. Int J Oncol 2002; 20: 23-29.
123. Vieille-Grosjean I, Huber P. Transcription factor GATA-1 regulates human HOXB2 gene expression in erythroid cells. J Biol Chem 1995; 270: 4544-4550.
124. Yu BD, Hanson RD, Hess JL, Horning SE, Korsmeyer SJ. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proc Natl Acad Sci U S A 1998; 95: 10 632-10 636.
125. van der Lugt NM, Alkema M, Berns A, Deschamps J. The Polycomb-group, homolog Bmi-1 is a regulator of murine Hox gene expression. Mech Dev 1996; 58: 153-164.
126. Chambeyron S, Bickmore WA. Chromatin decondensation and nuclear reorganization of the HoxB locus upon induction of transcription. Genes Dev 2004; 18: 1119-1130.
127. Bel-Vialar S, Itasaki N, Krumlauf R. Initiating Hox gene expression: in the early chick neural tube differential sensitivity to FGF and RA signaling subdivides the HoxB genes in two distinct groups. Development 2002; 129: 5103-5115.
128. McGuckin CP, Forraz N, Pettengell R, Thompson A. Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells. Cell Prolif 2004; 37: 295-306.
129. Prinsac GS, Birch L, Habermann H, et al. Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev 2001; 13: 241-252.
130. Cermik D, Karaca M, Taylor HS. HOXA10 expression is repressed by progesterone in the myometrium: differential tissue-specific regulation of HOX gene expression in the reproductive tract. J Clin Endocrinol Metab 2001; 86: 3387-3392.
131. Ma L, Benson GV, Lim H, Dey SK, Maas RL. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone, and repression in Müllerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 1998; 197: 141-154.
132. Chariot A, Castronovo V. Detection of HOXA1 expression in human breast cancer. Biochem Biophys Res Commun 1996; 222: 292-297.
133. Nonchev S, Vesque C, Maconochie M, et al. Segmental expression of Hoxa-2 in the hindbrain is directly regulated by Krox-20. Development 1996; 122: 543-554.
134. Vesque C, Maconochie M, Nonchev S, et al. Hoxb-2 transcriptional activation in rhombomeres 3 and 5 requires an evolutionarily conserved cis-acting element in addition to the Krox-20 binding site. EMBO J 1996; 15: 5383-5396.
135. Seitanidou T, Schneider-Maunoury S, Desmarquet C, Wilkinson DG, Charnay P. Krox-20 is a key regulator of rhombomere-specific gene expression in the developing hindbrain. Mech Dev 1997; 65: 31-42.
136. Manzanares M, Cordes S, Ariza-McNaughton L, et al. Conserved and distinct roles of kreisler in regulation of the paralogous Hoxa3 and Hoxb3 genes. Development 1999; 126: 759-769.
137. Gabellini D, Colaluca IN, Vodermaier HC, et al. Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression. EMBO J 2003; 22: 3715-3724.
138. Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Mol Cell 2004; 15: 57-67.
139. Inoue T, Chisaka O, Matsunami H, Takeichi M. Cadherin-6 expression transiently delineates specific rhombomeres, other neural tube subdivisions, and neural crest subpopulations in mouse embryos. Dev Biol 1997; 183: 183-194.
140. Shen J, Wu H, Gudas LJ. Molecular cloning and analysis of a group of genes differentially expressed in cells which overexpress the Hoxa-1 homeobox gene. Exp Cell Res 2000; 259: 274-283.
141. Packer AI, Elwell VA, Parnass JD, Knudsen KA, Wolgemuth DJ. N-cadherin protein distribution in normal embryos and in embryos carrying mutations in the homeobox gene Hoxa-4. Int J Dev Biol 1997; 41 459-468.
142. Chu MC, Selam FB, Taylor HS. HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells. Cancer Biol Ther 2004; 3: 568-572.
143. Leroy P, Berto F, Bourget I, Rossi B. Down-regulation of Hox A7 is required for cell adhesion and migration on fibronectin during early HL-60 monocytic differentiation. J Leukoc Biol 2004; 75 680-688.
144. Dorsam ST, Ferrell CM, Dorsam GP, et al. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood 2004; 103: 1676-1684.
145. Daftary GS, Troy PJ, Bagot CN, Young SL, Taylor HS. Direct regulation of beta3-integrin subunit gene expression by HOXA10 in endometrial cells. Mol Endocrinol 2002; 16: 571-579.
146. Care A, Silvani A, Meccia E, et al. HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol 1996; 16: 4842-4851.
147. Kwon Y, Ko JH, Byung-Gyu K, Kim MH, Kim B. Analysis of plausible downstream target genes of Hoxc8 in F9 teratocarcinoma cells. Putative downstream target genes of Hoxc8. Mol Biol Rep 2003; 30 141-148.
148. Awgulewitsch A. Hox in hair growth and development. Naturwissenschaften 2003; 90: 193-211.
149. Hall BK, Miyake T. All for one and one for all: condensations and the initiation of skeletal development. Bioessays 2000; 22 138-147.
150. Samad OA, Geisen MJ, Caronia G, et al. Integration of antero-posterior and dorsoventral regulation of Phox2b transcription in cranial motoneuron progenitors by homeodomain proteins. Development 2004; 131: 4071-4083.
151. Valerius MT, Patterson LT, Feng Y, Potter SS. Hoxa 11 is upstream of integrin alpha8 expression in the developing kidney. Proc Natl Acad Sci U S A 2002; 99: 8090-8095.